Georg Schett's guest appearances

Georg Schett

Cytokine Signalling Forum

Podcasts360

OwlTail

In this podcast, Georg Schett, MD, discusses the results and implications of his team’s recent study examining the tapering or stopping of medication in patients with rheumatoid arthritis who achieve stable remission.

Georg Schett, MD, on the Management of Rheumatoid Arthritis in Remission

Professor Georg Schett from the University of Erlangen-Nuremberg.Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Georg Schett discusses SARS-CoV-2 seroconversion in patients with immune-mediated inflammatory diseases receiving cytokine inhibitors.

Professor Georg Schett from the University of Erlangen-Nuremberg.<br>Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Georg Schett discusses SARS-CoV-2 seroconversion in patients with immune-mediated inflammatory diseases receiving cytokine inhibitors.

Rheumatology Author Georg Schett: SARS-CoV-2

Prof Schett from University of Erlangen-Nuremberg.Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can increase bone formation by stimulating osteoblasts.

Prof Schett from University of Erlangen-Nuremberg.<br>Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can increase bone formation by stimulating osteoblasts.